で組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
製品名
C17 Glucosyl(β) Ceramide (d18:1/17:0), Avanti Research™ - A Croda Brand 860569P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 25 mg (860569P-25mg), pkg of 1 × 5 mg (860569P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860569P
lipid type
sphingolipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
InChI
1S/C41H79NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37(45)42-34(33-49-41-40(48)39(47)38(46)36(32-43)50-41)35(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h28,30,34-36,38-41,43-44,46-48H,3-27,29,31-33H2,1-2H3,(H,42,45)/b30-28+/t34-,35+,36+,38+,39-,40+,
InChI key
VQADGGHNXABKOV-VIBFQTAGSA-N
General description
Glucosyl(β) Ceramide (β-GlcCer) is a naturally occurring glycolipid. It is also a ubiquitous intracellular metabolite.
Biochem/physiol Actions
Glucosyl(β) Ceramide (β-GlcCer) regulates the activity of natural killer T (NKT) lymphocytes and displays antimetastatic effects. It is an endogenous macrophage inducible C-type lectin (Mincle) ligand, which exhibits immunostimulatory property. β-GlcCer promotes inflammatory and acquired immune responses on myeloid cells via Mincle. It acts as a potential biomarker for Gaucher′s disease.
Packaging
5 mL Amber Glass Screw Cap Vial (860569P-25mg)
5 mL Amber Glass Screw Cap Vial (860569P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
保管分類
11 - Combustible Solids